BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30036524)

  • 1. Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.
    Khabou B; Mahjoub B; Barbu V; Balhoudi N; Wardani A; Sfar MT; Fakhfakh F
    Clin Chim Acta; 2018 Nov; 486():122-128. PubMed ID: 30036524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations Associated with Cholestasis with Different Phenotypes and Outcomes.
    Al-Hussaini A; Lone K; Bashir MS; Alrashidi S; Fagih M; Alanazi A; AlYaseen S; Almayouf A; Alruwaithi M; Asery A
    J Pediatr; 2021 Sep; 236():113-123.e2. PubMed ID: 33915153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
    Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
    Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
    Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
    J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.
    Chen R; Yang FX; Tan YF; Deng M; Li H; Xu Y; Ouyang WX; Song YZ
    Orphanet J Rare Dis; 2022 Dec; 17(1):445. PubMed ID: 36550572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.
    De Masi R; Orlando S; De Donno A
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2347-2350. PubMed ID: 31568708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
    Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
    BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Novel Missense Mutation in
    Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W
    Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
    Reichert MC; Lammert F
    Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
    Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
    Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of clinical characteristic of children with progressive familial intrahepatic cholestasis type 3].
    Cao LL; Yan JG; Feng DN; Dong Y; Xu ZQ; Wang FC; Gao YJ; Zhu SS; Zhang M
    Zhonghua Er Ke Za Zhi; 2024 May; 62(5):462-466. PubMed ID: 38623015
    [No Abstract]   [Full Text] [Related]  

  • 12. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
    Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
    J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
    Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
    J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up.
    Lipiński P; Ciara E; Jurkiewicz D; Płoski R; Wawrzynowicz-Syczewska M; Pawłowska J; Jankowska I
    Ann Hepatol; 2021; 25():100342. PubMed ID: 33757843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
    Pasmant E; Goussard P; Baranes L; Laurendeau I; Quentin S; Ponsot P; Consigny Y; Farges O; Condat B; Vidaud D; Vidaud M; Chen JM; Parfait B
    Eur J Hum Genet; 2012 Mar; 20(3):277-82. PubMed ID: 21989363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
    Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
    Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3.
    Poupon R; Barbu V; Chamouard P; Wendum D; Rosmorduc O; Housset C
    Liver Int; 2010 Feb; 30(2):327-31. PubMed ID: 19840255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
    Tan YW; Ji HL; Lu ZH; Ge GH; Sun L; Zhou XB; Sheng JH; Gong YH
    World J Gastroenterol; 2018 Nov; 24(41):4716-4720. PubMed ID: 30416319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).
    Degiorgio D; Colombo C; Seia M; Porcaro L; Costantino L; Zazzeron L; Bordo D; Coviello DA
    Eur J Hum Genet; 2007 Dec; 15(12):1230-8. PubMed ID: 17726488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.